High Ki67-LI was an independent predictor of increased disease specific mortality and biochemical recurrence in primarily intermediate-risk prostate cancer patients treated with RT or Radical prostatectomy [4, 5]. This evidence concerns the gene MKI67 and Familial prostate cancer.